Back to 
STATE STREET CORP
STATE STREET CORP
FDMT11 quarters
Position history for STATE STREET CORP's holdings in 4D MOLECULAR THERAPEUTICS IN
STATE STREET CORP holds 2.9M shares of FDMT (4D MOLECULAR THERAPEUTICS IN), worth $38.7M as of 2026-Q2. The position was increased (+7.5% shares). FDMT represents 0.0% of STATE STREET CORP's portfolio.
Current Value
$38.7M
Current Shares
2.9M
Total Value Change
+$7.8M
Total Shares Change
+1.4M
Quarter-by-Quarter History
Other major holders of FDMT: VIKING GLOBAL INVESTORS LP, RA CAPITAL MANAGEMENT, L.P., BlackRock Finance, Inc.